Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System

Statins accelerate disease progression and shorten survival in SOD1G93Amice

(2016) Xiaowei W. Su et al.   MUSCLE & NERVE

The effect of statins on average survival in randomised trials, an analysis of end point postponement: Table 1

(2015) Malene Lopez Kristensen et al.   BMJ Open

A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes

(2015) Keith B. Hoffman et al.   Journal of Managed Care & Specialty Pharmacy

Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum

(2014) Yufan Wu et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Misinterpretation of trial evidence on statin adverse effects may harm patients

(2014) Beatrice A Golomb   European Journal of Preventive Cardiology

Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: Implications for statin-induced rhabdomyolysis

(2013) Roger A. Vaughan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Simvastatin Effects on Skeletal Muscle

(2013) Steen Larsen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies

(2013) Payam Mohassel et al.   MUSCLE & NERVE

Selected statins produce rapid spinal motor neuron loss in vitro

(2012) Beth B Murinson et al.   BMC MUSCULOSKELETAL DISORDERS

A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class

(2012) Keith B. Hoffman et al.   PLoS One

Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis

(2012) Zhenzhen Zheng et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Necrotizing autoimmune myopathy

(2011) Christina Liang et al.   CURRENT OPINION IN RHEUMATOLOGY

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

(2010) Andrew L. Mammen et al.   ARTHRITIS AND RHEUMATISM

Statin Use and Risk of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

(2010) Henrik Toft Sørensen et al.  

Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis

(2010) Beatrice Nefussy et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Energy metabolism in amyotrophic lateral sclerosis

(2010) Luc Dupuis et al.   LANCET NEUROLOGY

Statin-Associated Muscle-Related Adverse Effects: A Case Series of 354 Patients

(2010) Stephanie Cham et al.   PHARMACOTHERAPY

Statin Adverse Effects

(2009) Beatrice A Golomb et al.   American Journal of Cardiovascular Drugs

Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs

(2009) Beatrice A. Golomb et al.   DRUG SAFETY

Lower serum lipid levels are related to respiratory impairment in patients with ALS

(2009) A. Chio et al.   NEUROLOGY

Quantitative signal detection using spontaneous ADR reporting

(2009) A. Bate et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis

(2008) Muddasir Qureshi et al.   Amyotrophic Lateral Sclerosis

Are statin medications safe in patients with ALS?

(2008) Lorne Zinman et al.   Amyotrophic Lateral Sclerosis

Genetic predisposition to statin myopathy

(2008) Georgirene D Vladutiu   CURRENT OPINION IN RHEUMATOLOGY

Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis

(2008) Takahiko Murata et al.   FREE RADICAL RESEARCH

Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis

(2008) Vivian E Drory et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

(2008) L. Dupuis et al.   NEUROLOGY

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system

(2008) Eric Colman et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis

(2007) Takahiko Murata et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES